Back to Journals » Psoriasis: Targets and Therapy

Psoriasis: Targets and Therapy


Journal Articles:

- 87 records -

The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East

Steinhoff M, Ammoury AF, Ahmed HM, Gamal MFS, El Sayed MH

Psoriasis: Targets and Therapy 2020, 10:23-28

Published Date: 20 August 2020

Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients

Anani HAA, Tawfeik AM, Maklad SS, Kamel AM, El-Said EE, Farag AS

Psoriasis: Targets and Therapy 2020, 10:13-21

Published Date: 21 May 2020

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives

Ly K, Beck KM, Smith MP, Orbai AM, Liao W

Psoriasis: Targets and Therapy 2019, 9:97-107

Published Date: 28 August 2019

Psoriasis and uveitis: links and risks

Fotiadou C, Lazaridou E

Psoriasis: Targets and Therapy 2019, 9:91-96

Published Date: 28 August 2019

A narrative review of psoriasis and multiple sclerosis: links and risks

Silfvast-Kaiser AS, Homan KB, Mansouri B

Psoriasis: Targets and Therapy 2019, 9:81-90

Published Date: 22 August 2019

Psoriasis and alcohol

Svanström C, Lonne-Rahm SB, Nordlind K

Psoriasis: Targets and Therapy 2019, 9:75-79

Published Date: 21 August 2019

Acrodermatitis continua of Hallopeau: clinical perspectives

Smith MP, Ly K, Thibodeaux Q, Bhutani T, Liao W, Beck KM

Psoriasis: Targets and Therapy 2019, 9:65-72

Published Date: 9 August 2019

Serum TSLP is a potential biomarker of psoriasis vulgaris activity

El-Ghareeb MI, Helmy A, Al Kazzaz S, Samir H

Psoriasis: Targets and Therapy 2019, 9:59-63

Published Date: 30 July 2019

Investigation of psoriasis skin tissue by label-free multi-modal imaging: a case study on a phototherapy-treated patient

Agarwal NR, Dowlatshahi Pour M, Vandikas MS, Neittaanmäki N, Osmancevic A, Malmberg P

Psoriasis: Targets and Therapy 2019, 9:43-57

Published Date: 17 July 2019

Diagnosis and screening of patients with generalized pustular psoriasis

Ly K, Beck KM, Smith MP, Thibodeaux Q, Bhutani T

Psoriasis: Targets and Therapy 2019, 9:37-42

Published Date: 20 June 2019

Spotlight on itolizumab in the treatment of psoriasis – current perspectives from India

Budamakuntla L, Shree-Lakshmi HV, Bansal A, Venkatarayaraju SK

Psoriasis: Targets and Therapy 2019, 9:19-27

Published Date: 3 May 2019

Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris

Strohbuecker L, Koenen H, van Rijssen E, van Cranenbroek B, Fasse E, Joosten I, Körber A, Bergmann C

Psoriasis: Targets and Therapy 2019, 9:7-17

Published Date: 12 February 2019

Type 2 diabetes and psoriasis: links and risks

Holm JG, Thomsen SF

Psoriasis: Targets and Therapy 2019, 9:1-6

Published Date: 17 January 2019

Psoriasis and sexual dysfunction: links, risks, and management challenges

Duarte GV, Calmon H, Radel G, Oliveira MDEF

Psoriasis: Targets and Therapy 2018, 8:93-99

Published Date: 10 December 2018

Secukinumab in the treatment of psoriasis: patient selection and perspectives

Yang EJ, Beck KM, Liao W

Psoriasis: Targets and Therapy 2018, 8:75-82

Published Date: 17 October 2018

Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients

Khan SA, Agrawal S, Baral N, Lamsal M

Psoriasis: Targets and Therapy 2018, 8:59-63

Published Date: 4 September 2018

The impact of genital psoriasis on quality of life: a systematic review

Yang EJ, Beck KM, Sanchez IM, Koo J, Liao W

Psoriasis: Targets and Therapy 2018, 8:41-47

Published Date: 28 August 2018

Targeting IL-23 in psoriasis: current perspectives

Fotiadou C, Lazaridou E, Sotiriou E, Ioannides D

Psoriasis: Targets and Therapy 2018, 8:1-5

Published Date: 4 January 2018

Drug-induced psoriasis: clinical perspectives

Balak DMW, Hajdarbegovic E

Psoriasis: Targets and Therapy 2017, 7:87-94

Published Date: 7 December 2017

Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives

Campanati A, Consales V, Orciani M, Giuliodori K, Ganzetti G, Bobyr I, Sorgentoni G, di Primio R, Offidani A

Psoriasis: Targets and Therapy 2017, 7:73-85

Published Date: 27 November 2017

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis

Sekhon S, Jeon C, Nakamura M, Yan D, Afifi L, Bhutani T, Levin E

Psoriasis: Targets and Therapy 2017, 7:65-72

Published Date: 16 November 2017

Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management

Cannizzaro MV, Franceschini C, Esposito M, Bianchi L, Giunta A

Psoriasis: Targets and Therapy 2017, 7:35-40

Published Date: 15 April 2017

Local effects of adipose tissue in psoriasis and psoriatic arthritis

Kruglikov IL, Wollina U

Psoriasis: Targets and Therapy 2017, 7:17-25

Published Date: 3 February 2017

The metabolomics of psoriatic disease

Yan D, Afifi L, Jeon C, Trivedi M, Chang HW, Lee K, Liao W

Psoriasis: Targets and Therapy 2017, 7:1-15

Published Date: 31 January 2017

Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability

Abrouk M, Levin E, Brodsky M, Gandy JR, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T

Psoriasis: Targets and Therapy 2016, 6:165-173

Published Date: 12 December 2016

Pustular psoriasis: pathophysiology and current treatment perspectives

Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B

Psoriasis: Targets and Therapy 2016, 6:131-144

Published Date: 12 September 2016

Psoriasis in children

Pinson R, Sotoodian B, Fiorillo L

Psoriasis: Targets and Therapy 2016, 6:121-129

Published Date: 20 October 2016

Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids

Svendsen MT, Andersen KE, Andersen F, Hansen J, Pottegård A, Johannessen H

Psoriasis: Targets and Therapy 2016, 6:113-119

Published Date: 23 August 2016

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability

Farahnik B, Patel V, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J

Psoriasis: Targets and Therapy 2016, 6:105-111

Published Date: 28 July 2016

Erythrodermic psoriasis: pathophysiology and current treatment perspectives

Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Liao W

Psoriasis: Targets and Therapy 2016, 6:93-104

Published Date: 20 July 2016

Psoriasis and inflammatory bowel disease: links and risks

Vlachos C, Gaitanis G, Katsanos KH, Christodoulou DK, Tsianos E, Bassukas ID

Psoriasis: Targets and Therapy 2016, 6:73-92

Published Date: 20 July 2016

Psoriasis and smoking: links and risks

Naldi L

Psoriasis: Targets and Therapy 2016, 6:65-71

Published Date: 27 May 2016

Assessment and monitoring of biologic drug adverse events in patients with psoriasis

Hanley T, Handford M, Lavery D, Yiu ZZN

Psoriasis: Targets and Therapy 2016, 6:41-54

Published Date: 1 April 2016

Management of scalp psoriasis: current perspectives

Blakely K, Gooderham M

Psoriasis: Targets and Therapy 2016, 6:33-40

Published Date: 29 March 2016

Current knowledge on psoriasis and autoimmune diseases

Ayala-Fontánez N, Soler DC, McCormick TS

Psoriasis: Targets and Therapy 2016, 6:7-32

Published Date: 22 February 2016

Links and risks associated with psoriasis and metabolic syndrome

Liakou AI, Zouboulis CC

Psoriasis: Targets and Therapy 2015, 5:125-128

Published Date: 2 November 2015

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast

Forchhammer S, Ghoreschi K

Psoriasis: Targets and Therapy 2015, 5:117-124

Published Date: 7 September 2015

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence

Yélamos O, Ros S, Puig L

Psoriasis: Targets and Therapy 2015, 5:109-115

Published Date: 17 July 2015

Psoriasis in pregnancy: challenges and solutions

Vena GA, Cassano N, Bellia G, Colombo D

Psoriasis: Targets and Therapy 2015, 5:83-95

Published Date: 18 May 2015

Epidemiology and treatment of psoriasis: a Brazilian perspective

Duarte GV, Porto-Silva L, Oliveira MdeFP

Psoriasis: Targets and Therapy 2015, 5:55-64

Published Date: 17 April 2015

Psoriasis in childhood: effective strategies to improve treatment adherence

Shah KN, Cortina S, Ernst MM, Kichler JC

Psoriasis: Targets and Therapy 2015, 5:43-54

Published Date: 16 March 2015

Clinical potential of brodalumab in the management of psoriasis: the evidence to date

Sandoval LF, Williams B, Feldman SR

Psoriasis: Targets and Therapy 2015, 5:35-41

Published Date: 11 March 2015

Optimal management of nail disease in patients with psoriasis

Piraccini BM, Starace M

Psoriasis: Targets and Therapy 2015, 5:25-33

Published Date: 9 January 2015

Fumaric acid esters in the management of psoriasis

Balak DMW

Psoriasis: Targets and Therapy 2015, 5:9-23

Published Date: 5 January 2015

Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study

Narayanan S, Guyatt V, Franceschetti A, Hautamaki EL

Psoriasis: Targets and Therapy 2015, 5:1-7

Published Date: 23 December 2014

Epidemiology and treatment of psoriasis: a Chinese perspective

Pan R, Zhang JZ

Psoriasis: Targets and Therapy 2014, 4:37-47

Published Date: 13 October 2014

Emerging treatment options for psoriasis

Taheri A, Sandoval LF, Moradi Tuchayi S, Alinia H, Mansoori P, Feldman SR

Psoriasis: Targets and Therapy 2014, 4:27-35

Published Date: 18 August 2014

Self-management in patients with psoriasis

Pathak SN, Scott PL, West C, Feldman SR

Psoriasis: Targets and Therapy 2014, 4:19-26

Published Date: 10 July 2014

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis

Nicolazzo D, Kerdel F, Kerdel F

Psoriasis: Targets and Therapy 2014, 4:11-18

Published Date: 24 June 2014

Long-term safety of biologics in the treatment of psoriasis

Panchal MR, Coope H, McKenna DJ, Alexandroff AB

Psoriasis: Targets and Therapy 2014, 4:1-9

Published Date: 12 December 2013

Biologic therapy and tuberculosis: our experience and review of literature

Fabroni C, D'Erme AM, Lotti T

Psoriasis: Targets and Therapy 2013, 3:25-29

Published Date: 3 July 2013

Management of guttate psoriasis in patients with associated streptococcal infection

Karabudak Abuaf O, Dogan B

Psoriasis: Targets and Therapy 2012, 2:89-94

Published Date: 20 November 2012

Safety profiles of topical vitamin D3 in psoriasis patients: a retrospective large-scale study

Yamamoto A, Furuhashi T, Matsumoto K, Morita A

Psoriasis: Targets and Therapy 2012, 2:81-88

Published Date: 15 November 2012

Lipid profile in psoriasis patients

Bhat RM, Pinto HP

Psoriasis: Targets and Therapy 2012, 2:77-80

Published Date: 9 November 2012

Psoriasis: epidemiology, natural history, and differential diagnosis

Basko-Plluska JL, Petronic-Rosic V

Psoriasis: Targets and Therapy 2012, 2:67-76

Published Date: 11 September 2012

Biomarkers in the pathogenesis, diagnosis, and treatment of psoriasis

Molteni S, Reali E

Psoriasis: Targets and Therapy 2012, 2:55-66

Published Date: 4 September 2012

The management of psoriasis through diet

Duarte G, Barbosa LO, Rosa ME

Psoriasis: Targets and Therapy 2012, 2:45-53

Published Date: 7 August 2012

Biologics in the treatment of psoriasis and emerging new therapies in the pipeline

Levy LL, Solomon SM, Emer JJ

Psoriasis: Targets and Therapy 2012, 2:29-43

Published Date: 18 June 2012

Plaque psoriasis in children and adolescents – the role of etanercept

Ricceri F, Tripo L, Pescitelli L, Prignano F

Psoriasis: Targets and Therapy 2012, 2:25-28

Published Date: 11 June 2012

Quality of life issues and measurement in patients with psoriasis

Tan X, Feldman SR, Balkrishnan R

Psoriasis: Targets and Therapy 2012, 2:13-23

Published Date: 21 February 2012

Editorial

Bagel J

Psoriasis: Targets and Therapy 2011, 1:1-2

Published Date: 23 June 2011